I agree that this site is using cookies. You can find further informations here.
X
Bianchini, Giampaolo
162  results:
Search for persons X
?
1

Prognostic significance of a signature based on senescence-..:

Ungvari, Zoltan ; Ungvari, Anna ; Bianchini, Giampaolo.
GeroScience.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

Navigating practical challenges in immunotherapy for metast..:

Licata, Luca ; Dieci, Maria Vittoria ; De Angelis, Carmine...
Cancer Treatment Reviews.  128 (2024)  - p. 102762 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Corrigendum to "Breaking barriers in triple negative breast..:

Dri, Arianna ; Arpino, Grazia ; Bianchini, Giampaolo...
Cancer Treatment Reviews.  125 (2024)  - p. 102714 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Tailoring treatment of luminal A and lobular breast cancer ..:

Di Micco, Rosa ; Canevari, Carla ; Gallivanone, Francesca...
European Journal of Surgical Oncology.  50 (2024)  2 - p. 107474 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Management of Trastuzumab Deruxtecan-related nausea and vom..:

Notini, Giulia ; Naldini, Matteo Maria ; Sica, Lorenzo...
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
6

Breaking barriers in triple negative breast cancer (TNBC) –..:

Dri, Arianna ; Arpino, Grazia ; Bianchini, Giampaolo...
Cancer Treatment Reviews.  123 (2024)  - p. 102672 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Monitoring of neoadjuvant chemotherapy through time domain ..:

Mule, Nikhitha ; Maffeis, Giulia ; Cubeddu, Rinaldo...
Biomedical Optics Express.  , 2024
Link: https://doi.org/10.1364/..
 
?
8

Real-world use of multigene signatures in early breast canc..:

Licata, Luca ; De Sanctis, Rita ; Vingiani, Andrea...
Breast Cancer Research and Treatment.  205 (2024)  1 - p. 39-48 , 2024
Link: https://doi.org/10.1007/..
 
?
9

Trastuzumab deruxtecan versus trastuzumab emtansine in HER2..:

Cortés, Javier ; Hurvitz, Sara A. ; Im, Seock-Ah...
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
10

Trastuzumab deruxtecan versus treatment of physician's choi..:

André, Fabrice ; Hee Park, Yeon ; Kim, Sung-Bae...
The Lancet.  401 (2023)  10390 - p. 1773-1785 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Tissue- and liquid biopsy-based biomarkers for immunotherap..:

Licata, Luca ; Mariani, Marco ; Rossari, Federico...
The Breast.  69 (2023)  - p. 330-341 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Design of SERENA-6, a phase III switching trial of camizest..:

Turner, Nicholas ; Huang-Bartlett, Cynthia ; Kalinsky, Kevin...
Future Oncology.  19 (2023)  8 - p. 559-573 , 2023
Link: https://doi.org/10.2217/..
 
?
13

Oncotype DX results increase concordance in adjuvant chemot..:

Licata, Luca ; Viale, Giulia ; Giuliano, Mario...
npj Breast Cancer.  9 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
14

Trastuzumab deruxtecan versus trastuzumab emtansine in pati..:

Hurvitz, Sara A ; Hegg, Roberto ; Chung, Wei-Pang...
The Lancet.  401 (2023)  10371 - p. 105-117 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Tucatinib's journey from clinical development to clinical p..:

Criscitiello, Carmen ; Corti, Chiara ; De Laurentiis, Michelino...
Cancer Treatment Reviews.  120 (2023)  - p. 102618 , 2023
Link: https://doi.org/10.1016/..
 
1-15